Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
2. Gibraltar Industries, Inc.
36.9% sales growth and 11.75% return on equity
Gibraltar Industries, Inc. manufactures and distributes building products for the renewable energy, conservation, residential, and infrastructure markets in North America and Asia.
Gibraltar Industries, Inc.'s sales growth this year is anticipated to be 27.8% and 7.5% for next year.
Year-on-year quarterly revenue growth grew by 2.7%, now sitting on 1.03B for the twelve trailing months.
Gibraltar Industries, Inc.'s sales growth for the next quarter is 36.9%. The company's growth estimates for the ongoing quarter and the next is 6.4% and 13.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.75%.
Volatility
Gibraltar Industries, Inc.'s last day, last week, and last month's current volatility was 0.51%, 1.06%, and 2.44%, respectively.
Gibraltar Industries, Inc.'s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.25% (day), 2.87% (last week), and 4.51% (last month), respectively.
Gibraltar Industries, Inc.'s Stock Yearly Top and Bottom Value
Gibraltar Industries, Inc.'s stock is valued at $89.83 at 05:22 EST, way under its 52-week high of $103.02 and way higher than its 52-week low of $36.39.
Gibraltar Industries, Inc.'s Moving Average
Gibraltar Industries, Inc.'s value is above its 50-day moving average of $89.06 and way above its 200-day moving average of $79.35.3. CRA International,Inc.
9.4% sales growth and 12.05% return on equity
CRA International, Inc., a consulting company, provides economic, financial, and management consulting services in the United States, the United Kingdom, and internationally.
CRA International,Inc.'s sales growth this year is expected to be 6.3% and 6.6% for next year.
Year-on-year quarterly revenue growth grew by 15.2%, now sitting on 508.37M for the twelve trailing months.
CRA International,Inc.'s sales growth for the next quarter is 9.4%. The company's growth estimates for the ongoing quarter and the next is a negative 1.2% and 7.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.05%.
Volatility
CRA International,Inc.'s last day, last week, and last month's current volatility was 3.00%, 2.41%, and 2.26%, respectively.
CRA International,Inc.'s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.50% (day), 4.08% (last week), and 4.05% (last month), respectively.
CRA International,Inc.'s Stock Yearly Top and Bottom Value
CRA International,Inc.'s stock is valued at $76.41 at 05:22 EST, below its 52-week high of $77.21 and way higher than its 52-week low of $31.73.
CRA International,Inc.'s Moving Average
CRA International,Inc.'s worth is higher than its 50-day moving average of $70.19 and way above its 200-day moving average of $54.43.4. VirTra, Inc.
83% sales growth and 13.54% return on equity
VirTra, Inc. provides force training simulators, firearms training simulators, and driving simulators for law enforcement, military, educational, and civilian worldwide.
VirTra, Inc.'s sales growth this year is anticipated to be 13.3% and 9.6% for next year.
Year-on-year quarterly revenue growth grew by 11.4%, now sitting on 19.09M for the twelve trailing months.
VirTra, Inc.'s sales growth is a negative 0% for the ongoing quarter and 83% for the next. The company's growth estimates for the ongoing quarter and the next is 80% and 137.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.54%.
Volatility
VirTra, Inc.'s last day, last week, and last month's current volatility was 6.77%, 2.77%, and 7.75%, respectively.
VirTra, Inc.'s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 11.16% (day), 7.42% (last week), and 9.02% (last month), respectively.
VirTra, Inc.'s Stock Yearly Top and Bottom Value
VirTra, Inc.'s stock is valued at $5.05 at 05:22 EST, way below its 52-week high of $10.17 and way above its 52-week low of $2.00.
VirTra, Inc.'s Moving Average
VirTra, Inc.'s value is under its 50-day moving average of $5.18 and way higher than its 200-day moving average of $4.36.5. Grand Canyon Education, Inc.
13% sales growth and 17.05% return on equity
Grand Canyon Education, Inc. provides education services to colleges and universities in the United States.
Grand Canyon Education, Inc.'s sales growth this year is anticipated to be 9.6% and 8.6% for next year.
Year-on-year quarterly revenue growth grew by 11.7%, now sitting on 844.1M for the twelve trailing months.
Grand Canyon Education, Inc.'s sales growth for the next quarter is 13%. The company's growth estimates for the present quarter and the next is 9.2% and 5.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 17.05%.
Volatility
Grand Canyon Education, Inc.'s last day, last week, and last month's current volatility was 0.32%, 0.63%, and 1.18%, respectively.
Grand Canyon Education, Inc.'s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.67% (day), 1.78% (last week), and 2.44% (last month), respectively.
Grand Canyon Education, Inc.'s Stock Yearly Top and Bottom Value
Grand Canyon Education, Inc.'s stock is valued at $111.73 at 05:22 EST, under its 52-week high of $114.48 and way above its 52-week low of $72.25.
Grand Canyon Education, Inc.'s Moving Average
Grand Canyon Education, Inc.'s worth is higher than its 50-day moving average of $107.09 and way higher than its 200-day moving average of $91.66.6. Quidel Corporation
197.5% sales growth and 85.63% return on equity
Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications in infectious diseases, cardiology, thyroid, women's and general health, eye health, gastrointestinal diseases, and toxicology worldwide.
Quidel Corporation's sales growth this year is expected to be 38.8% and a negative 37.9% for next year.
Year-on-year quarterly revenue growth grew by 431.7%, now sitting on 1.66B for the twelve trailing months.
Quidel Corporation's sales growth for the next quarter is 197.5%. The company's growth estimates for the current quarter and the next is 318.9% and 238.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 85.63%.
Volatility
Quidel Corporation's last day, last week, and last month's current volatility was 2.26%, 2.05%, and 2.27%, respectively.
Quidel Corporation's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 4.53% (day), 4.58% (last week), and 4.62% (last month), respectively.
Quidel Corporation's Stock Yearly Top and Bottom Value
Quidel Corporation's stock is valued at $122.32 at 05:22 EST, way under its 52-week high of $306.72 and way above its 52-week low of $86.30.
Quidel Corporation's Moving Average
Quidel Corporation's worth is way under its 50-day moving average of $151.95 and way under its 200-day moving average of $203.14.7. Charles River Laboratories International, Inc.
29.4% sales growth and 19.17% return on equity
Charles River Laboratories International, Inc., an early-stage contract research company, provides drug discovery, non-clinical development, and safety testing services.
Charles River Laboratories International, Inc.'s sales growth this year is expected to be 15.6% and 10.2% for next year.
Year-on-year quarterly revenue growth grew by 14.4%, now sitting on 2.92B for the twelve trailing months.
Charles River Laboratories International, Inc.'s sales growth for the next quarter is 29.4%. The company's growth estimates for the present quarter and the next is 19% and 34.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 19.17%.
Volatility
Charles River Laboratories International, Inc.'s last day, last week, and last month's current volatility was 0.94%, 1.33%, and 1.50%, respectively.
Charles River Laboratories International, Inc.'s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.38% (day), 2.07% (last week), and 2.56% (last month), respectively.
Charles River Laboratories International, Inc.'s Stock Yearly Top and Bottom Value
Charles River Laboratories International, Inc.'s stock is valued at $323.38 at 05:22 EST, above its 52-week high of $320.95.